221 related articles for article (PubMed ID: 16302824)
1. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
J Med Chem; 2005 Dec; 48(24):7860-6. PubMed ID: 16302824
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Minakuchi T; Onishi S; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2007 Jan; 50(2):381-8. PubMed ID: 17228881
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
Nishimori I; Minakuchi T; Onishi S; Vullo D; Cecchi A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2007 Dec; 15(23):7229-36. PubMed ID: 17826101
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
Innocenti A; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(22):5703-7. PubMed ID: 15482952
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
Innocenti A; Firnges MA; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):1149-54. PubMed ID: 15686931
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
Vullo D; Innocenti A; Nishimori I; Pastorek J; Scozzafava A; Pastoreková S; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):963-9. PubMed ID: 15686894
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.
De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
Smaine FZ; Pacchiano F; Rami M; Barragan-Montero V; Vullo D; Scozzafava A; Winum JY; Supuran CT
Bioorg Med Chem Lett; 2008 Dec; 18(24):6332-5. PubMed ID: 18990571
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
Nishimori I; Minakuchi T; Morimoto K; Sano S; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2006 Mar; 49(6):2117-26. PubMed ID: 16539401
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library.
Davis RA; Innocenti A; Poulsen SA; Supuran CT
Bioorg Med Chem; 2010 Jan; 18(1):14-8. PubMed ID: 19962903
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: the inhibition profiles of the human mitochondrial isoforms VA and VB with anions are very different.
Nishimori I; Innocenti A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem; 2007 Nov; 15(21):6742-7. PubMed ID: 17761422
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.
Isik S; Kockar F; Aydin M; Arslan O; Guler OO; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2009 Feb; 17(3):1158-63. PubMed ID: 19124253
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
Nishimori I; Vullo D; Minakuchi T; Morimoto K; Onishi S; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Apr; 16(8):2182-8. PubMed ID: 16459077
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.
Vullo D; Franchi M; Gallori E; Antel J; Scozzafava A; Supuran CT
J Med Chem; 2004 Feb; 47(5):1272-9. PubMed ID: 14971907
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
Bioorg Med Chem Lett; 2005 Sep; 15(17):3828-33. PubMed ID: 16039848
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
Minakuchi T; Nishimori I; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2009 Apr; 52(8):2226-32. PubMed ID: 19317447
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
Lehtonen JM; Parkkila S; Vullo D; Casini A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Jul; 14(14):3757-62. PubMed ID: 15203157
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT
Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]